131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates (Q74658560)
Jump to navigation
Jump to search
scientific article published on 01 January 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates |
scientific article published on 01 January 2002 |
Statements
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates (English)
Eva Cavallin-Ståhl
Ola Lindén
Jan Tennvall
Cecilia Hindorf
Karl-Johan Lindner
Tomas Ohlsson
Karin Wingårdh
Sven-Erik Strand